Dr. Karmella Haynes is tackling resistant triple-negative breast cancer through chromatin engineering. As this cancer type disproportionately affects Black women, Haynes seeks not only to advance chromatin science but to improve health outcomes for medically underserved patients.
A New Approach To A Deadly Breast Cancer Offers Hope To The Black Women It Affects Most
